Toxoplasma gondii IgG Seroprevalence in Patients with HIV/AIDS

Toxoplasmosis is a common opportunistic infection in patients with HIV/AIDS and may cause life-threatening clinical courses, such as encephalitis and pneumonia. Patients admitted between January 2006 and August 2017 with anti-HIV positivity confirmed by Western blotting were included in the study. D...

Full description

Saved in:
Bibliographic Details
Published in:Türkiye parazitolojii dergisi Vol. 42; no. 3; pp. 175 - 179
Main Authors: Senoglu, Sevtap, Yesilbag, Zuhal, Altuntas Aydin, Ozlem, Kumbasar Karaosmanoglu, Hayat, Kart Yasar, Kadriye
Format: Journal Article
Language:English
Published: Turkey Galenos Publishing House 01-09-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Toxoplasmosis is a common opportunistic infection in patients with HIV/AIDS and may cause life-threatening clinical courses, such as encephalitis and pneumonia. Patients admitted between January 2006 and August 2017 with anti-HIV positivity confirmed by Western blotting were included in the study. Demographic data, CD4+ T-lymphocyte counts, and Toxoplasma gondii IgG/IgM levels were retrospectively obtained from patient records. T. gondii IgM positivity was not detected in patients, whereas T. gondii IgG positivity was detected in 267 (43.5%) patients. The T. gondii IgG positivity rate was 37.6% in men who had sex with men (MSM) and 48.4% in heterosexual patients. Furthermore, 42.6% of MSM and 21% of heterosexual patients were university graduates, of which T. gondii IgG positivity was detected in only 33.6% of MSM patients and 42.3% of heterosexual patients. In our study, high seronegativity was remarkable in MSM patients, particularly those who were highly educated, thus emphasizing the importance of prevention of primary infection in seronegative patients; necessity of prophylaxis in appropriate patients due to encephalitis, which has a high mortality rate and almost always develops after a latent infection; and necessity of screening for toxoplasmosis seropositivity at the time of diagnosis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2146-3077
1300-6320
2146-3077
DOI:10.5152/tpd.2018.5706